EUVIMEDEUVIMED entdecken
Crossref

Regulation of fibroblast phenotype in osteoarthritis using CDKN1A-loaded copper sulfide nanoparticles delivered by mesenchymal stem cells

Hong Liu iD, Ming Ji, Tao Yang, Shihua Zou, Xingan Qiu, Fangbiao Zhan, Jian Chen, Fei Yan, Fan Ding, Ping Li iD

American Journal of Physiology-Cell Physiology · 2025

DOI: 10.1152/ajpcell.00573.2024 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Physiology-Cell Physiology, 2025. Verfasst von Hong Liu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics, Chongqing University Three Gorges Hospital, Chongqing, People's Republic of China. Hauptthemen laut MEDLINE: Mesenchymal Stem Cells, Copper, Fibroblasts, Osteoarthritis. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 74 Literaturangaben. Gefördert von: Chongqing University Three Gorges Hospital, Wanzhou district of Chongqing phD train Research Project, Wanzhou District Science and Health Joint Major Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study introduces MSCs@CuS@CDKN1A, a nanoengineered MSC platform that targets fibroblast phenotypes in osteoarthritis (OA). By modulating CDKN1A expression, this innovative approach not only enhances cartilage repair but also effectively mitigates fibroblast-driven inflammation, marking a significant advancement in OA therapeutics with demonstrated efficacy and biocompatibility.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mesenchymal Stem CellsCopperFibroblastsOsteoarthritisCyclin-Dependent Kinase Inhibitor p21NanoparticlesMesenchymal Stem Cell TransplantationAnimalsMicePhenotypeHumansCell ProliferationChondrocytesMaleMice, Inbred C57BL

Stichwörter der Autor:innen

CDKN1Afibroblastsmesenchymal stem cellsnanoparticlesosteoarthritis

Substanzen

CopperCyclin-Dependent Kinase Inhibitor p21

Autor:innen und Institutionen

  • Department of Orthopedics, Chongqing University Three Gorges Hospital, Chongqing, People's Republic of China.
  • Chongqing Municipality Clinical Research Center for Geriatric Diseases, Chongqing, People's Republic of China.
  • School of Medicine, Chongqing University, Chongqing, People's Republic of China.
  • Department of Orthopedics, General Hospital of Central Theater Command, Wuhan, People's Republic of China.
  • Division of Orthopedics, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, People's Republic of China.

ORCID-Profile: Hong Liu, Ping Li

Förderung

  • Chongqing University Three Gorges Hospital
  • Wanzhou district of Chongqing phD train Research Project
  • Wanzhou District Science and Health Joint Major Project
  • Scientific Research Project of Chongqing Doctor Direct Train
  • Doctoral Research Start-Up Fund of Chongqing University Three Gorges Hospital
  • Fundamental Research Funds for the Key Research Program of Chongqing Science and Technology Commission
  • GDSTC | Natural Science Foundation of Guangdong Province ()

Zitieren

APA

Liu, H., Ji, M., Yang, T., Zou, S., Qiu, X., Zhan, F., Chen, J., Yan, F., Ding, F., & Li, P. (2025). Regulation of fibroblast phenotype in osteoarthritis using CDKN1A-loaded copper sulfide nanoparticles delivered by mesenchymal stem cells. American Journal of Physiology-Cell Physiology. https://doi.org/10.1152/ajpcell.00573.2024

Vancouver

Liu H, Ji M, Yang T, Zou S, Qiu X, Zhan F, et al. Regulation of fibroblast phenotype in osteoarthritis using CDKN1A-loaded copper sulfide nanoparticles delivered by mesenchymal stem cells. American Journal of Physiology-Cell Physiology. 2025. doi:10.1152/ajpcell.00573.2024

BibTeX
@article{Liu2025,
  author = {Liu, Hong and Ji, Ming and Yang, Tao and Zou, Shihua and Qiu, Xingan and Zhan, Fangbiao and Chen, Jian and Yan, Fei and Ding, Fan and Li, Ping},
  title = {Regulation of fibroblast phenotype in osteoarthritis using CDKN1A-loaded copper sulfide nanoparticles delivered by mesenchymal stem cells},
  journal = {American Journal of Physiology-Cell Physiology},
  year = {2025},
  doi = {10.1152/ajpcell.00573.2024}
}
Kostenlos starten →